Abstract:[Background] Antibiotic resistance is arguably the biggest current threat to global health and animal husbandry development. As an emerging solution, bacteriophage can specifically infect and kill bacteria, thus becoming a candidate substitute of antibiotics to enable healthy development of the animal husbandry. [Objective] To study the molecular biological characteristics of the cashmere goat-associated Escherichia coli virulent bacteriophage φPTK, and use mouse model to examine the effect of φPTK in the prevention and treatment of E. coli infections, so as to provide a new strategy for effective control of E. coli infections in cashmere goats.[Methods] The φPTK was concentrated with polyethylene glycol (PEG) 8000-sodium chloride (NaCl) and then the morphological structure was observed by transmission electron microscopy. The nucleic acid of φPTK was extracted with phenol-chloroform method, and the whole genome was sequenced by Illumina HiSeq. Mauve was employed for comparative genomics analysis, and the polygenetic tree was plotted by MEGA. Finally, the effect of φPTK in the prevention and treatment of E. coli infection in mice was analyzed.[Results] The φPTK had isometric head (90 nm diameter) and long contractile tail (about 112 nm in length and 18 nm in diameter). The genome was 169 688 bp with GC content of 37.72% and 264 open reading frames (ORFs). It had the holin-lysin lysis system, anti-holin and lysis inhibition accessory protein, and no virulence-associated and antibiotic resistance genes. The comparative genome analysis indicated it was a novel lytic cashmere goat-associated E. coli bacteriophage. φPTK was applied before and after E. coli infection in mice for prevention and treatment. The result showed that all mice in the positive control group without φPTK died, and the survival rate of mice in the prevention and treatment groups reached 80% and 60%, respectively. [Conclusion] The virulent cashmere goat-associated E. coli phage φPTK (Myoviridae, Caudovirale) is effective in the prevention and treatment of E. coli infections. This study lays a basis for the development of bacteriophage agents for biological control of colibacillosis in cashmere goats.